8:00 a.m.

Blood/Marrow Transplantation (BMT): The Donor Selection Process, Claudio Brunstein, MD, University of Minnesota Health

Learning Objectives:

1. Describe matched related donors, unrelated donors and alternative donors for BMT.
2. Identify determining factors when selecting a donor and stem cell source for an allogeneic BMT.

8:45 a.m.

Current Management Options for Multiple Myeloma; Making Sense of Alphabet Soup, Brian McClune, DO, University of Minnesota Health

Learning Objectives:

1. Define when myeloma requires treatment and important prognostic markers.
2. Discuss treatment options for non-transplant eligible patients.
3. List first and second generation novel agents.
4. Review treatment options for transplant-eligible patients and those that have relapsed.

9:45 a.m.

Novel Uses of Cellular Therapies, Sarah Cooley, MD, MS, University of Minnesota Health

Learning Objectives:

1. Describe emerging trends in the use of cellular therapies.

10:30 a.m.

Treatment and Management of Myelodysplastic Syndrome (MDS): Strategies to Optimize Outcomes, Erica Warlick, MD, University of Minnesota Health

Learning Objectives:

1. Define the role of transplantation for MDS.
2. Discuss the appropriate timing for transplantation for MDS in the context of alternative available therapies.
3. Compare and contrast transplantation for MDS with non-hematopoietic-stem-cell transplant therapy.
4. Identify the appropriate therapies for lower- and higher-risk MDS and the novel agents being developed.

12:30 p.m.

Acute Myelogenous Leukemia (AML), Celalettin Ustun, MD, University of Minnesota Health

Learning Objectives:

1. Identify evolving molecular markers and treatment options.
2. Identify appropriate therapeutic strategies for the older patient with AML.
3. Discuss why the consideration of performance status, comorbidities and quality of life are important for successful long-term treatment goals.

1:15 p.m.

BMT as a Treatment Option for Pediatric Niche Diseases, Paul Orchard, MD, University of Minnesota Health

Learning Objectives:

1. Identify types of rare niche diseases wherein transplant is an option.
2. Discuss outcomes of allogeneic BMT for the treatment of inherited inborn errors of metabolism.

2:15 p.m.

Diagnosis, Treatment and Outcomes for Patients With Lymphoma, Veronika Bachanova, MD, University of Minnesota Health

Learning Objectives:

1. State the different types of lymphoma.
2. Review the diagnosis, treatment and survival rates of Hodgkin and non-Hodgkin lymphoma.

3:00–4:00 p.m.

Unrelated Cord Blood and Epidermolysis Bullosa as a Novel Therapeutic Application, John Wagner, MD, University of Minnesota Health

Learning Objectives:

1. Describe transplant outcome expectations in recipients of unrelated cord blood transplantation in relation to other stem cell sources.
2. Discuss risk factors for engraftment, relapse and event-free survival after unrelated cord blood transplant.
3. Review outcomes in recipients of ex vivo expansion of umbilical cord blood hematopoietic stem cells and regulatory T cells as strategies to speed hematopoietic recovery and reduce the risk of graft-versus-host disease.
4. Review the rationale and transplant outcomes in patients with severe epidermolysis bullosa.